—
Last 30 days
Recent Press Releases & News
Apollomics Receives Nasdaq Deficiency Notice Over Market Value Requirement
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Overview
52-week range
—
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Jul 24, 2026 | Mar/2026 | OTHER | — | — |
Implied volatility — last 90 days
No IV snapshots yet for APLM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.